Medicare Enrolled
Dr. Michael Lobianco, D.O.
Family Medicine · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lobianco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lobianco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lobianco
Dr. Michael Lobianco is a family medicine specialist in Philadelphia, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Lobianco performed 1,327 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lobianco received a total of $13,696 from 52 pharmaceutical and/or device companies across 834 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lobianco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 18% volume in PA
$13,696 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,327
Medicare services
Top 18% in PA for family medicine
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
398 | $58 | $125 |
| Annual depression screening | 151 | $19 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
145 | $133 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
136 | $90 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
75 | $8 | $10 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
72 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
68 | $72 | $75 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
68 | $50 | $85 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
55 | $41 | $60 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
55 | $40 | $55 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
34 | $34 | $45 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
21 | $26 | $50 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
19 | $223 | $350 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $11 | $65 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
12 | $36 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$13,696
Total received (2018-2024)
Avg $1,957/year across 7 years
Top 4% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
834
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,069
2023
$2,349
2022
$2,247
2021
$2,025
2020
$1,465
2019
$1,649
2018
$1,893
Payments by company (2024)
GlaxoSmithKline, LLC.
$261
AstraZeneca Pharmaceuticals LP
$252
Novo Nordisk Inc
$241
Lilly USA, LLC
$199
ABBVIE INC.
$197
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$162
Otsuka America Pharmaceutical, Inc.
$104
PFIZER INC.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
Amgen Inc.
$76
Astellas Pharma US Inc
$70
Takeda Pharmaceuticals U.S.A., Inc.
$60
Exact Sciences Corporation
$59
Esperion Therapeutics, Inc.
$46
Almatica Pharma LLC
$36
Bausch Health US, LLC
$33
SANOFI PASTEUR INC.
$27
IDORSIA PHARMACEUTICALS US INC
$22
Vanda Pharmaceuticals Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,419
Novo Nordisk Inc
$1,065
Lilly USA, LLC
$1,038
GlaxoSmithKline, LLC.
$1,013
ABBVIE INC.
$877
Boehringer Ingelheim Pharmaceuticals, Inc.
$844
PFIZER INC.
$775
Amgen Inc.
$702
Takeda Pharmaceuticals U.S.A., Inc.
$613
Janssen Pharmaceuticals, Inc
$509
Astellas Pharma US Inc
$446
AbbVie Inc.
$432
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$395
Merck Sharp & Dohme Corporation
$278
Kowa Pharmaceuticals America, Inc.
$238
Allergan Inc.
$213
Bayer Healthcare Pharmaceuticals Inc.
$200
Otsuka America Pharmaceutical, Inc.
$192
Abbott Laboratories
$186
Allergan, Inc.
$186
Teva Pharmaceuticals USA, Inc.
$185
Novartis Pharmaceuticals Corporation
$164
SANOFI PASTEUR INC.
$156
Exact Sciences Corporation
$145
Merck Sharp & Dohme LLC
$113
Dexcom, Inc.
$113
Endo Pharmaceuticals Inc.
$91
Esperion Therapeutics, Inc.
$90
AbbVie, Inc.
$85
Amarin Pharma Inc.
$85
Xeris Pharmaceuticals, Inc.
$84
Corcept Therapeutics
$80
Almatica Pharma LLC
$73
Bayer HealthCare Pharmaceuticals Inc.
$72
Alexion Pharmaceuticals, Inc.
$68
Greer Laboratories, Inc.
$57
Regeneron Healthcare Solutions, Inc.
$55
Eisai Inc.
$52
IDORSIA PHARMACEUTICALS US INC
$43
Biohaven Pharmaceutical Holding Company Ltd.
$36
Bausch Health US, LLC
$33
Axsome Therapeutics, Inc.
$32
VistaPharm, Inc.
$24
Sanofi Pasteur Inc.
$24
Hikma Pharmaceuticals USA
$22
Vanda Pharmaceuticals Inc.
$21
Celgene Corporation
$19
Seqirus USA Inc
$18
Purdue Pharma L.P.
$14
E.R. Squibb & Sons, L.L.C.
$13
ARBOR PHARMACEUTICALS, INC.
$11
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
ADACEL · ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · Aimovig · Auvelity · BASAGLAR · BELSOMRA · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CHANTIX · CREON · CYCLOSET · Cologuard Collection Kit · Creon · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FANAPT · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · GARDASIL 9 · GEMTESA · GRALISE · GVOKE PFS · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LOREEV XR · LYRICA · Livalo · MENACTRA · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NASCOBAL · NEXLETOL · NURTEC ODT · ORALAIR · OXYCONTIN · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIRIS · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Strensiq · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thyquidity · Tresiba · Trintellix · UBRELVY · Ultomiris · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Vyvanse · WELLBUTRIN · XARELTO · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
2,443
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
NAZARETH HOSPITAL
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lobianco is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lobianco experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lobianco performed 398 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lobianco receive payments from pharmaceutical companies?
Yes. Dr. Lobianco received a total of $13,696 from 52 companies across 834 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lobianco's costs compare to other family medicine physicians in Philadelphia?
Dr. Lobianco's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lobianco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Philadelphia
Browse family medicine physicians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology